Automated Breast Ultrasound System Market to Reach US$4.3 Billion by 2033

According to Fact.MR, a supplier of market research and competitive intelligence, the global automated breast ultrasound system market is predicted to grow at a 9.7% CAGR to reach US $4.3 billion by the end of 2033.

Automated Breast Ultrasound Systems (ABUS) are sophisticated breast imaging devices that use sound waves to produce detailed images of breast tissue. They are especially useful for women who have thick breasts, when standard mammography may be ineffective. ABUS is safe because it does not use radiation, making it an excellent choice for repeated examinations. It complements mammography, giving a more comprehensive screening method. ABUS may provide 3D images, which provide a more detailed perspective of the breasts. It's also less painful for people than some other methods.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=585

The market for automated breast ultrasonography systems is growing primarily due to increased knowledge of breast density and its impact on mammography accuracy. As legislative obligations in several places require alerting women about their breast density, there is a growing demand for supplementary screening instruments such as automated breast ultrasonography devices.

Smaller healthcare facilities may struggle to afford ABUS systems, which aid in the early detection of breast cancer. This financial barrier can limit access, particularly for clinics with limited resources or those operating on a low budget. Some healthcare providers may struggle with the use of automated breast ultrasound devices (ABUS). They require appropriate training to operate and interpret the results appropriately.

Mammograms and automated ultrasound systems are two screening methods that are helping many women understand the importance of early detection of breast cancer. Furthermore, it is projected that over the next several years, market participants would have more opportunities due to the increasing need for sophisticated technology for cancer diagnosis and detection.

An rise in healthcare spending helps diagnostic centers employ specialized diagnostic equipment. By using advanced diagnostic imaging equipment, these clinics offer better medical care to patients with breast cancer. The increasing patient preference for specialist diagnostic choices will propel the installation of breast cancer detection technology across these facilities.

The lack of radiologists and the requirement that current radiologists undergo ultrasound imaging training are two constraints that are limiting the market for automated breast ultrasound systems. A lack of investment from key companies in the development of new technology and economic uncertainty are two major challenges limiting the global market for automated breast ultrasonography systems.

Recent price trends indicate that the high cost of ultrasound devices compared to traditional cancer screening methods is impeding market growth. availability chain management is being disrupted in a number of nations due to strict laws that have limited the local availability of automated breast ultrasound imaging procedures. Ultrasonography can detect cancer quickly and effectively, but it can also result in false-positive biopsies, which is predicted to limit market growth.

Which Region Holds a Dominating Position in the Industry?

Because of the high incidence of breast cancer and the presence of several significant competitors, North America holds a 50% market share for ABUS worldwide. The factors boosting market value include technological developments in automated breast ultrasonography devices that detect breast cancer in densely cellular breast tissue.

The market is expanding as a result of increased public and private sector initiatives to increase awareness of breast cancer early detection and treatment.

Country-wise Insights

The market in the United States is anticipated to grow as a result of the rise in government initiatives to inform women about breast cancer, the rising need for screening due to elevated cancer awareness, and the expanding demand for sophisticated breast imaging technologies.

Rapid urbanization, the existence of an established healthcare infrastructure, favorable insurance policies, rising consumer healthcare spending, and the growing need for sophisticated non-invasive breast imaging procedures are the main factors propelling the German market for automated breast ultrasound systems.

In order to comply with strict government regulations and requirements, market participants in Germany are working to optimize the automated breast ultrasonography market. The market need for automated breast ultrasound systems will benefit from the construction of cutting-edge cancer diagnostic facilities.

Category-wise Insights

The market is segmented by product: automated breast ultrasound systems and automated breast volume scanners. Automated breast volume scanners account for 50% of the global market.

Automated breast volume scanners use high-frequency ultrasound light to accurately assess lactiferous ducts and evaluate volumetric images of the breast. The growing preference among patients for least invasive diagnostic approaches is boosting the demand for automated breast volume scanners.

Real-time imaging support is offered to guide these scanners. Other advantages of automated breast volume scanners include quick and painless treatments and enhanced diagnostic accuracy, which aids in the early diagnosis of breast cancer.

The market is split into hospitals and diagnostic centres based on the end user. Hospitals are increasingly deploying automated breast ultrasound systems to meet the diagnostic demands of their patients. The increased usage of cancer screening tests among young and middle-aged women will be the key driver of demand for ABUS in various healthcare settings. Because pregnant women are unable to undergo mammography due to radiation risks, hospitals are introducing automated breast ultrasonography systems to provide safer diagnostic alternatives.

Competitive Landscape

Traditional portable ultrasound systems have limitations when utilized for breast cancer screening, such as a longer screening time and difficulty operating the system. Leading firms are concentrating on developing new automated breast ultrasonography systems to overcome the limitations of traditional equipment. Key market participants are focusing on integrating automated breast ultrasound systems with full-field digital mammography (FFDM) to establish a unified platform capable of producing higher-quality pictures.

Top market participants are prioritizing the installation of automated breast ultrasound systems in medical facilities and diagnostic centers by safety laws in order to reduce environmental effect and grow global presence. In addition to achieving regulatory clearance for their goods, they are also looking to increase the accuracy of automated breast ultrasound devices for a faster assessment of